Abel Hall LLC’s Axcelis ACLS Stock Holding History

Abel Hall LLC’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244K	Sell	2,617 -12	-0.5%	-$1.06K	0.05%	510
2025 Q4	$211K	Buy	+2,629	New	+$220K	0.05%	514

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Abel Hall LLC's ACLS Position: Q1 2026 in Review

Abel Hall LLC reduced its Axcelis (ACLS) stake by 0.46% in Q1 2026, selling an estimated $1.06K and leaving 2,617 shares worth $244K. The position accounts for 0.05% of the portfolio, ranked #510.

Abel Hall LLC first reported a position in ACLS in Q4 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

Abel Hall LLC held 2,617 shares of Axcelis worth $244K as of Q1 2026.
Abel Hall LLC sold 12 Axcelis shares in Q1 2026, an estimated $1.06K.
Axcelis made up 0.05% of Abel Hall LLC's portfolio in Q1 2026, its #510 holding.
Abel Hall LLC first reported a position in Axcelis in Q4 2025 and has held it in 2 quarters since.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.